Please join us for a special session featuring Dr. Julie Paik, Associate Professor of Rheumatology and current Co-director of the Johns Hopkins Myositis Center. Dr. Paik will present top-line results from the recently completed Phase 3 VALOR trial of brepocitinib in dermatomyositis, the largest randomized trial ever conducted in dermatomyositis to date. This session is recommended for anyone with interest in rheumatic disease, clinical trial design, and/or emerging targeted therapies.
.png)